[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100357303":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":48,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":10,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Northwestern University","OTHER",[8,11,13,15,17,19],{"label":9,"type":10,"description":10,"interventionNames":10},"Stage IA-IIA cutaneous T cell lymphoma",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Stage IIB and above cutaneous T cell lymphoma",{"label":14,"type":10,"description":10,"interventionNames":10},"CD30+ lymphoproliferative disorders",{"label":16,"type":10,"description":10,"interventionNames":10},"Plaque psoriasis with BSA>5% on routine phototherapy",{"label":18,"type":10,"description":10,"interventionNames":10},"Moderate to severe atopic dermatitis on routine bleach bath",{"label":20,"type":10,"description":10,"interventionNames":10},"Healthy controls",[22],{"name":23,"affiliation":5,"role":24},"Alan Zhou, MD","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Dermatology CTU","CONTACT","312-503-5944","NUderm-research@northwestern.edu",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Chicago","Illinois","60611","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-87.65005,41.85003,{"lat":43,"lon":42},[46,47],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},{"name":23,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":24,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Xiaolong (Alan) Zhou","Principal Investigator","100357303","characterization-of-the-microbiome-in-cutaneous-t-cell-lymphoma-100357303",false,"NCT03932279","Characterization of the Microbiome in Cutaneous T Cell Lymphoma","Inclusion Criteria:\n\n* Group 1: Patients with stage IA-IIA cutaneous T cell lymphoma\n* Group 2: Patients with stage IIB and above cutaneous T cell lymphoma\n* Group 3: Patients with CD30+ lymphoproliferative disorder including lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma\n* Group 4: Patients with plaque psoriasis with BSA\\>5% on routine phototherapy per standard of care\n* Group 5: Patients with moderate to severe atopic dermatitis on routine bleach bath therapy per standard of care\n* Group 6: Healthy individuals without the above skin conditions, similar age and sex distribution to the patients with cutaneous T cell lymphoma\n* All Groups: subjects who are age 18-89 years of age at time of enrollment\n* All Groups: Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443).\n\nExclusion Criteria:\n\n* All Groups: Subjects who are younger than 18 years of age or older than 90 years of age\n* All Groups: Subjects who are unable to give consent\n* Patients currently on systemic antibiotics or recent (within past 4 weeks) exposure to systemic antibiotics\n* We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.",true,"ALL","18 Years","89 Years",{"count":62,"type":63},300,"ESTIMATED","OBSERVATIONAL","Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.",[67],"Cutaneous T Cell Lymphoma","2026-04-27",{"date":70,"type":71},"2026-05-01","ACTUAL",{"date":73,"type":71},"2019-01-30",{"date":75,"type":63},"2028-08-31",{"name":5,"class":6},1]